STXBP1 Variants Associated With Epilepsy With Variable Severity
CNS Neuroscience & Therapeutics · 2026-08 · 32 (8)
DOI: 10.1002/cns.71093 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 17.08.2026. Verfasst von Meng Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Edu…. Hauptthemen laut MEDLINE: Munc18 Proteins, Epilepsy, Genetic Variation. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province, Guangzhou Municipal Education Burean.
Abstract (Originalsprache)
Introduction
Pathogenic variants in STXBP1 are a well‐established cause of developmental and epileptic encephalopathy (DEE), whereas their contribution to milder epilepsy phenotypes remains under‐characterized. We sought to delineate STXBP1 variants across a clinical severity spectrum and to explore molecular correlates of phenotypic heterogeneity.
Methods
Trio‐based whole‐exome sequencing was performed in patients with unexplained epilepsy recruited from multiple epilepsy centers. Variants were confirmed by Sanger sequencing and interpreted using ACMG criteria. Missense variants were assessed using structural modeling and biophysical prediction tools, and their effects on Munc18‐1 expression were evaluated by immunoblotting in transfected HEK293T cells.
Results
Eight STXBP1 variants were identified in eight unrelated cases, including one truncating variant (Lys63Ter) and seven missense variants. Five de novo missense variants (Pro187Leu, Arg190Gln, Ala251Thr, Arg292His, and Gly544Val) and one de novo truncating variant were observed exclusively in individuals with DEE. In contrast, Gly236Val segregated in a family with epilepsy with febrile seizures plus, and Pro434Leu was inherited in a family with self‐limited epilepsy with centrotemporal spikes with incomplete penetrance. In silico analyses suggested that Gly236Val and Pro434Leu had comparatively milder destabilizing effects and were located at more solvent‐accessible positions than DEE‐associated variants. Consistently, immunoblotting showed markedly reduced Munc18‐1 levels for DEE‐associated missense variants, whereas Gly236Val and Pro434Leu preserved similar Munc18‐1 levels to wild‐type expression.
Conclusions
STXBP1 variants may underlie epilepsies of variable severity, extending from milder epilepsy syndromes to DEE. Clinical severity broadly tracks with the predicted structural/biophysical impact of the variant and Munc18‐1 abundance, providing a mechanistic clue for phenotypic heterogeneity in STXBP1 ‐related disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical Uni…
- The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, China.
- Department of Medical Genetics/Experimental Education/Administration Center, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
- Genetic and Metabolic Center Laboratory, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
- Hainan Provincial Key Laboratory for Human Reproductive Medicine and Genetic Research & Hainan Provincial Clinical, The First Affiliated Hospital of Hainan Medical University, Hainan Medical University, Haikou, China.
ORCID-Profile: Meng Xu, Xuan Guo, Zhi-Kui Wang, Yang Qi, Yi-Wu Shi, Fu Xiong, Xiao-Rong Liu
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangzhou Municipal Education Burean
Zitieren
APA
Xu, M., Guo, X., Wang, Z. K., Qi, Y., Ye, T. T., Xu, J., Deng, W. W., Zhuang, M. Z., Shi, Y. W., Xiong, F., Liu, X. R., & China Epilepsy Gene 1.0 Project (2026). STXBP1 Variants Associated With Epilepsy With Variable Severity. CNS Neuroscience & Therapeutics, 32(8). https://doi.org/10.1002/cns.71093
Vancouver
Xu M, Guo X, Wang ZK, Qi Y, Ye TT, Xu J, et al. STXBP1 Variants Associated With Epilepsy With Variable Severity. CNS Neuroscience & Therapeutics. 2026;32(8). doi:10.1002/cns.71093
BibTeX
@article{Xu2026,
author = {Xu, Meng and Guo, Xuan and Wang, Zhi-Kui and Qi, Yang and Ye, Ting-Ting and Xu, Jie and Deng, Wei-Wen and Zhuang, Min-Zhi and Shi, Yi-Wu and Xiong, Fu and Liu, Xiao-Rong and China Epilepsy Gene 1.0 Project, China Epilepsy Gene 1.0 Project},
title = {STXBP1 Variants Associated With Epilepsy With Variable Severity},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {8},
doi = {10.1002/cns.71093}
}
EUVIMED